{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:58:08Z","timestamp":1791903488588,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jsbmb.2009.12.009","type":"journal-article","created":{"date-parts":[[2009,12,29]],"date-time":"2009-12-29T04:07:10Z","timestamp":1262059630000},"page":"177-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer"],"prefix":"10.1016","volume":"118","author":[{"given":"Michael C.","family":"Byrns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor M.","family":"Penning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","article-title":"Intracrinology: role of the family of 17\u03b2-hydroxysteroid dehydrogenases in human physiology and disease","volume":"25","author":"Labrie","year":"2000","journal-title":"J. Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.009_bib2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1677\/erc.1.00834","article-title":"Sex steroid-producing enzymes in human breast cancer","volume":"12","author":"Suzuki","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"issue":"Pt 1","key":"10.1016\/j.jsbmb.2009.12.009_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1\u2013AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsbmb.2009.12.009_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-6-27","article-title":"Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors","volume":"6","author":"Harris","year":"2006","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.009_bib5","first-page":"613","article-title":"NSAIDs and breast cancer recurrence in a prospective cohort study","volume":"18","author":"Kwan","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.009_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/aje\/kwm195","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort","volume":"166","author":"Gill","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.009_bib7","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.jsbmb.2009.12.009_bib8","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.ejca.2006.08.014","article-title":"A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer","volume":"42","author":"Canney","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.009_bib9","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1210\/jc.2004-2029","article-title":"Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells","volume":"90","author":"Diaz-Cruz","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.009_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2007.09.008","volume":"75","author":"Byrns","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.009_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/mol.104.006569","article-title":"Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes","volume":"67","author":"Bauman","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"23","key":"10.1016\/j.jsbmb.2009.12.009_bib12","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17\u03b2-Hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer","volume":"66","author":"Jansson","year":"2006","journal-title":"Cancer Res."},{"issue":"13\u201314","key":"10.1016\/j.jsbmb.2009.12.009_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.steroids.2004.09.014","article-title":"Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3\u03b1-hydroxysteroid dehydrogenase\/type 5 17\u03b2-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate","volume":"69","author":"Lin","year":"2004","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.009_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00795-007-0365-8","article-title":"In situ production of sex steroids in human breast carcinoma","volume":"40","author":"Suzuki","year":"2007","journal-title":"Med. Mol. Morphol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mce.2005.12.009","article-title":"Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors","volume":"248","author":"Penning","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2005.10.024","article-title":"Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues","volume":"248","author":"Sharma","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.009_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/endo.140.2.6531","article-title":"Characteristics of a highly labile human type 5 17\u03b2-hydroxysteroid dehydrogenase","volume":"140","author":"Dufort","year":"1999","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.009_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/oxfordjournals.jbchem.a022211","article-title":"Identification of a principal mRNA species for human 3\u03b1-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity","volume":"124","author":"Matsuura","year":"1998","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.009_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-5793(99)01551-3","article-title":"cDNA cloning, expression and characterization of human prostaglandin F synthase","volume":"462","author":"Suzuki-Yamamoto","year":"1999","journal-title":"FEBS Lett."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mrfmmm.2008.12.010","article-title":"The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis","volume":"662","author":"Birtwistle","year":"2009","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.009_bib21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/jc.2002-021368","article-title":"Prostaglandin (PG) F2\u03b1 receptor expression and signaling in human endometrium: role of PGF2\u03b1 in epithelial cell proliferation","volume":"88","author":"Milne","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.009_bib22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2003-031434","article-title":"Expression, localization, and signaling of prostaglandin F2\u03b1 receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways","volume":"89","author":"Sales","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"17","key":"10.1016\/j.jsbmb.2009.12.009_bib23","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1158\/0008-5472.CAN-05-0101","article-title":"A novel angiogenic role for prostaglandin F2\u03b1-FP receptor interaction in human endometrial adenocarcinomas","volume":"65","author":"Sales","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.009_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0019-2805.2001.01340.x","article-title":"Prostaglandin D2, its metabolite 15-d-PGJ2, and peroxisome proliferator activated receptor-\u03b3 agonists induce apoptosis in transformed, but not normal, human T lineage cells","volume":"105","author":"Harris","year":"2002","journal-title":"Immunology"},{"issue":"14","key":"10.1016\/j.jsbmb.2009.12.009_bib25","doi-asserted-by":"crossref","first-page":"14145","DOI":"10.1074\/jbc.M500901200","article-title":"\u03b1,\u03b2-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor \u03b3","volume":"280","author":"Shiraki","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.009_bib26","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/0008-5472.CAN-06-3043","article-title":"15-Deoxy-\u039412,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-\u03b1 via covalent modification of DNA-binding domain","volume":"67","author":"Kim","year":"2007","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.009_bib27","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-Deoxy-\u039412,14-prostaglandin J2 inhibits multiple steps in the NF-\u03baB signaling pathway","volume":"97","author":"Straus","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"19","key":"10.1016\/j.jsbmb.2009.12.009_bib28","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1021\/bi972725u","article-title":"Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[\u03b1]pyrene-7,8-dione","volume":"37","author":"Burczynski","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2009.12.009_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0076-6879(07)33009-7","article-title":"Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI\/MS)","volume":"433","author":"Lee","year":"2007","journal-title":"Methods Enzymol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2008.08.026","article-title":"Relative involvement of three 17\u03b2-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors","volume":"301","author":"Laplante","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.009_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006217400137","article-title":"17\u03b2-Hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue","volume":"57","author":"Miettinen","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"issue":"20","key":"10.1016\/j.jsbmb.2009.12.009_bib32","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1158\/0008-5472.CAN-04-0446","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer","volume":"64","author":"Oduwole","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.009_bib33","first-page":"936","article-title":"The 4-pregnene and 5\u03b1-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion","volume":"60","author":"Wiebe","year":"2000","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.009_bib34","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol. Endocrinol."},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.009_bib35","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1210\/me.2007-0443","article-title":"Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms","volume":"22","author":"Hardy","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2003.12.006","article-title":"The role of 17\u03b2-hydroxysteroid dehydrogenases","volume":"218","author":"Mindnich","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2009.12.009_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0960-0760(97)00068-X","article-title":"Autocrine and paracrine actions of breast tumor aromatase. A three dimensional cell culture study involving aromatase transfected MCF-7 and T47D cells","volume":"63","author":"Sun","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.009_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mce.2006.04.029","article-title":"Paracrine-stimulated gene expression profile favors estradiol production in breast tumors","volume":"253","author":"Amin","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.009_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/mol.65.4.973","article-title":"The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase","volume":"65","author":"Nomura","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.009_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/bbrc.1997.6433","article-title":"Prostaglandin F2\u03b1 receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium","volume":"233","author":"Serrero","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"34","key":"10.1016\/j.jsbmb.2009.12.009_bib41","doi-asserted-by":"crossref","first-page":"24897","DOI":"10.1016\/S0021-9258(18)35848-4","article-title":"Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle","volume":"267","author":"Dorn","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2009.12.009_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2407-8-49","article-title":"Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women","volume":"8","author":"Sauter","year":"2008","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.009_bib43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjc.6604049","article-title":"Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy","volume":"97","author":"Schonthal","year":"2007","journal-title":"Br. J. Cancer"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:33:52Z","timestamp":1760744032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076009003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0960076009003021"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.12.009","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}